Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster Polio Vaccine (Sabin IPV vs bOPV) in 4-Year-Olds
NCT04576910Phase 4Completed
- Start
- Nov 2020
- Primary completion
- Jun 2021
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Inactivated poliovirus vaccine (Sabin strain) and bivalent oral poliovirus vaccine in poliomyelitis (5 arms). Primary endpoints: Seroconversion rates of the booster vaccination, Persistence of antibodies against poliovirus and 1 more. Started Nov 2020; status: completed.
02
Drugs
Inactivated poliovirus vaccine (Sabin strain)bivalent oral poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT04576910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04576910.